For: | Sezaki T, Hirata Y, Hagiwara T, Kawamura YI, Okamura T, Takanashi R, Nakano K, Tamura-Nakano M, Burkly LC, Dohi T. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice. World J Gastroenterol 2017; 23(13): 2294-2307 [PMID: 28428709 DOI: 10.3748/wjg.v23.i13.2294] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i13/2294.htm |
Number | Citing Articles |
1 |
Ourania S. Kotsiou, Konstantinos I. Gourgoulianis, Sotirios G. Zarogiannis. IL-33/ST2 Axis in Organ Fibrosis. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02432
|
2 |
Guanglei Hu, Weihui Zeng, Yumin Xia. TWEAK/Fn14 signaling in tumors. Tumor Biology 2017; 39(6): 101042831771462 doi: 10.1177/1010428317714624
|
3 |
Jennifer Duffen, Melvin Zhang, Katherine Masek-Hammerman, Angela Nunez, Agnes Brennan, Jessica E. C. Jones, Jeffrey Morin, Karl Nocka, Marion Kasaian. Modulation of the IL-33/IL-13 Axis in Obesity by IL-13Rα2. The Journal of Immunology 2018; 200(4): 1347 doi: 10.4049/jimmunol.1701256
|
4 |
Olena Zaitseva, Annett Hoffmann, Christoph Otto, Harald Wajant. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.935086
|